Scannell Timothy J's Form 4 filing
NovoCure Ltd (NVCR) · filed Jun 6, 2024
- Accession no.
- 0001562180-24-004759
- Filed
- Jun 6, 2024
- Trade date
- Jun 4-5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $23.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scannell Timothy JCIK 0001451533 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | Ordinary Shares | SSaleDisposed | −964 | $23.89 | −$23,029.96 | 2,964 | Direct | |
| Jun 5, 2024 | Restricted Stock Units | AGrant or awardAcquired | +4,053 | $0.00 | $0 | 7,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Ordinary Shares | AGrant or awardAcquired | +6,229 | $0.00 | $0 | 6,229 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.